2-(2,5-dioxopyrrol-1-yl)ethyl-oxo-[3-oxo-3-(2-oxopyrrolidin-1-yl)oxypropyl]phosphanium
C13H16N2O6P+ — CID 123150805
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(2,5-dioxopyrrol-1-yl)ethyl-oxo-[3-oxo-3-(2-oxopyrrolidin-1-yl)oxypropyl]phosphanium
2-(2,5-dioxopyrrol-1-yl)ethyl-oxo-[3-oxo-3-(2-oxopyrrolidin-1-yl)oxypropyl]phosphanium (PubChem CID 123150805) has the molecular formula C13H16N2O6P+ and a molecular weight of 327.25 g/mol. Its IUPAC name is 2-(2,5-dioxopyrrol-1-yl)ethyl-oxo-[3-oxo-3-(2-oxopyrrolidin-1-yl)oxypropyl]phosphanium.
Molecular Properties
| Compound Name | 2-(2,5-dioxopyrrol-1-yl)ethyl-oxo-[3-oxo-3-(2-oxopyrrolidin-1-yl)oxypropyl]phosphanium |
|---|---|
| PubChem CID | 123150805 |
| Molecular Formula | C13H16N2O6P+ |
| Molecular Weight | 327.25 g/mol |
| Exact Mass | 327.07 |
| IUPAC Name | 2-(2,5-dioxopyrrol-1-yl)ethyl-oxo-[3-oxo-3-(2-oxopyrrolidin-1-yl)oxypropyl]phosphanium |
| SMILES | O=C(CC[P+](=O)CCN1C(=O)C=CC1=O)ON1CCCC1=O |
| InChI | InChI=1S/C13H16N2O6P/c16-10-3-4-11(17)14(10)7-9-22(20)8-5-13(19)21-15-6-1-2-12(15)18/h3-4H,1-2,5-9H2/q+1 |
| InChIKey | OEHSNTBPFRTAGW-UHFFFAOYSA-N |
| XLogP | 0.21 |
| TPSA | 101.06 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 22 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 327.25 |
| LogP ≤ 5 | 0.21 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123150805 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.